100 Million Vaccine Doses By End Of June

>>Follow Matzav On Whatsapp!<<

Johnson & Johnson said Tuesday that it is on track to meet its target of 100 million coronavirus vaccine doses for the United States by the end of June, one of a string of confident announcements on vaccine supply.

Johnson & Johnson is being closely watched as a potential third vaccine for the U.S., helping further an increase in available doses. The company said Tuesday that it expects results from its Phase 3 trial “by early next week.”

If the vaccine proves to be safe and effective and is authorized in the coming weeks, the company’s chief financial officer, Joseph Wolk, told CNBC: “We’re very confident and on track to meet all of our commitments, which would include 100 million doses to the U.S. by the end of June.”

Read more at The Hill.




Please enter your comment!
Please enter your name here